BTYNB was found to restrain the binding of IGFBP1 to c-Myc mRNA and downregulate mRNA transcripts, including c-Myc, eEF2, and β-TrCP1 in ovarian cancer cells. Here, IGFBP1 is linked to ovarian carcinoma.